{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:44:11Z","timestamp":1792269851631,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","soard.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery for Obesity and Related Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.soard.2026.09.012","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:51:43Z","timestamp":1790135503000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Total healthcare costs and cost savings after bariatric surgery and glucagon-like peptide-1 receptor agonist treatment for obesity and diabetes vary with insurance coverage"],"prefix":"10.1016","author":[{"given":"Mohammad E.","family":"Alomari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2480-8875","authenticated-orcid":false,"given":"Elizabeth","family":"Wall-Wieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-5566","authenticated-orcid":false,"given":"Feibi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4811-0789","authenticated-orcid":false,"given":"Michael A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.soard.2026.09.012_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes \u2014 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.soard.2026.09.012_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/HYPERTENSIONAHA.118.12290","article-title":"Effects of bariatric surgery versus medical therapy on the 24-Hour ambulatory blood pressure and the prevalence of resistant hypertension: the GATEWAY randomized clinical trial","volume":"73","author":"Schiavon","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.soard.2026.09.012_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2014.16968","article-title":"Association between bariatric surgery and long-term survival","volume":"313","author":"Arterburn","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.soard.2026.09.012_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/SLA.0000000000005003","article-title":"Patient-reported outcomes after metabolic surgery versus medical therapy for diabetes: insights from the STAMPEDE randomized trial","volume":"274","author":"Aminian","year":"2021","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.soard.2026.09.012_bib5","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1111\/dom.16353","article-title":"Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: a multi-institutional propensity score-matched study","volume":"27","author":"Wu","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.soard.2026.09.012_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000540534","article-title":"Effect of dual glucagon-like peptide 1\/Glucose-Dependent insulinotropic polypeptide receptor agonist (Tirzepatide) versus bariatric surgery on weight loss and nonalcoholic fatty liver disease","volume":"33","author":"Al-Sabah","year":"2024","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.soard.2026.09.012_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.sleep.2025.02.010","article-title":"Efficacy and safety of GLP-1 receptor agonists in the management of obstructive sleep apnea in individuals without diabetes: a systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"129","author":"Kow","year":"2025","journal-title":"Sleep Med"},{"key":"10.1016\/j.soard.2026.09.012_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2025.116242","article-title":"Metabolic and bariatric surgery versus glucagon-like peptide-1 receptor agonist therapy: a comparison of cardiovascular outcomes in patients with obesity","volume":"242","author":"Maan","year":"2025","journal-title":"Am J Surg"},{"issue":"10","key":"10.1016\/j.soard.2026.09.012_bib9","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamacardio.2020.1966","article-title":"Use of glucagon-like Peptide-1 receptor agonists in patients with type 2 diabetes and cardiovascular disease: a review","volume":"5","author":"Honigberg","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"14","key":"10.1016\/j.soard.2026.09.012_bib10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.soard.2026.09.012_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.soard.2026.09.012_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-089477","article-title":"Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis","volume":"15","author":"Squire","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.soard.2026.09.012_bib13","first-page":"S17","article-title":"Comparative effectiveness of semaglutide and tirzepatide vs bariatric surgery","volume":"241","author":"Brown","year":"2025","journal-title":"J Am Coll Surg"},{"issue":"11","key":"10.1016\/j.soard.2026.09.012_bib14","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamasurg.2025.3590","article-title":"Obesity treatment with bariatric surgery vs GLP-1 receptor agonists","volume":"160","author":"Barrett","year":"2025","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.soard.2026.09.012_bib15","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1038\/s41591-025-03893-3","article-title":"Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity","volume":"31","author":"Gasoyan","year":"2025","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.soard.2026.09.012_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194749","article-title":"GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity","volume":"135","author":"Cooper","year":"2025","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.soard.2026.09.012_bib17","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1111\/dom.16627","article-title":"A cost-effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada","volume":"27","author":"Gupta","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.soard.2026.09.012_bib18","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1007\/s00464-024-11191-1","article-title":"A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point?","volume":"38","author":"Docimo","year":"2024","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.soard.2026.09.012_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000028","article-title":"Association between medicaid status, social determinants of health, and bariatric surgery outcomes","volume":"2","author":"Liu","year":"2021","journal-title":"Ann Surg Open"},{"issue":"10","key":"10.1016\/j.soard.2026.09.012_bib20","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.soard.2019.07.010","article-title":"Bariatric surgery is safe and effective in medicare patients regardless of age: an analysis of primary gastric bypass and sleeve gastrectomy outcomes","volume":"15","author":"Petrick","year":"2019","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1016\/j.soard.2026.09.012_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41366-018-0131-0","article-title":"Insurance status differences in weight loss and regain over 5 years following bariatric surgery","volume":"42","author":"Takemoto","year":"2018","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"10.1016\/j.soard.2026.09.012_bib22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/oby.22312","article-title":"Reduction in comorbid conditions over 5 years following bariatric surgery in medicaid and commercially insured patients","volume":"26","author":"Takemoto","year":"2018","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.soard.2026.09.012_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/jof12040293","article-title":"Duration of antifungal therapy in disseminated coccidioidomycosis patients: a real-world treatment utilization study","volume":"12","author":"Coleman","year":"2026","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.soard.2026.09.012_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/14799731241310897","article-title":"Real-world disease burden, mortality, and healthcare resource utilization associated with bronchiectasis","author":"Shoaib","year":"2025","journal-title":"Chron Respir Dis"},{"issue":"4","key":"10.1016\/j.soard.2026.09.012_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.clinthera.2022.01.017","article-title":"Greater adherence and persistence with injectable dulaglutide compared with injectable semaglutide at 1-Year follow-up: data from US clinical practice","volume":"44","author":"Mody","year":"2022","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.soard.2026.09.012_bib27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/pds.4377","article-title":"Validation of an algorithm for identifying type 1 diabetes in adults based on electronic health record data","volume":"27","author":"Schroeder","year":"2018","journal-title":"Pharmacoepidemiol Drug"},{"key":"10.1016\/j.soard.2026.09.012_bib29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.6004","article-title":"A comparison of 12 algorithms for matching on the propensity score","volume":"33","author":"Austin","year":"2014","journal-title":"Statist Med"},{"issue":"8","key":"10.1016\/j.soard.2026.09.012_sref30","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jclinepi.2013.01.013","article-title":"Prognostic score\u2013based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research","volume":"66","author":"Stuart","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.soard.2026.09.012_sref31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.soard.2023.12.017","article-title":"Equity in bariatric surgery use: acohort study","volume":"20","author":"Gershuni","year":"2024","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"10.1016\/j.soard.2026.09.012_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/SLA.0000000000003554","article-title":"Changes in utilization of Bariatric Surgery in the United States from 1993 to 2016","volume":"271","author":"Campos","year":"2020","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.soard.2026.09.012_bib32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamasurg.2015.1250","article-title":"Patient and referring practitioner characteristics associated with the likelihood of undergoing bariatric surgery: a systematic review","volume":"150","author":"Funk","year":"2015","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.soard.2026.09.012_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.soard.2019.12.022","article-title":"American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States","volume":"16","author":"English","year":"2020","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"10.1016\/j.soard.2026.09.012_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.48317","article-title":"Estimated cost-effectiveness of medical therapy, sleeve gastrectomy, and gastric bypass in patients with severe obesity and type 2 diabetes","volume":"5","author":"Lauren","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.soard.2026.09.012_bib35","first-page":"569","article-title":"Medications for obesity management: effectiveness and value","volume":"29","author":"Atlas","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"11","key":"10.1016\/j.soard.2026.09.012_bib36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.7326\/ANNALS-24-03609","article-title":"The cost-effectiveness of semaglutide and tirzepatide for patients with knee Osteoarthritis and obesity","volume":"178","author":"Betensky","year":"2025","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.soard.2026.09.012_bib37","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1007\/s00464-023-10411-4","article-title":"Association of program-specific variation in bariatric surgery volume for medicaid patients and access to care: a tale of inequality?","volume":"37","author":"Somerset","year":"2023","journal-title":"Surg Endosc"},{"issue":"10","key":"10.1016\/j.soard.2026.09.012_bib38","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1007\/s00464-025-12087-4","article-title":"Identifying drivers of disparities in post-surgical healthcare resource utilization for bariatric surgery","volume":"39","author":"Magura","year":"2025","journal-title":"Surg Endosc"},{"issue":"2","key":"10.1016\/j.soard.2026.09.012_bib39","doi-asserted-by":"crossref","DOI":"10.4293\/JSLS.2022.00009","article-title":"Rates of readmission and emergency department visits of publicly versus commercially insured patients in a metabolic and bariatric surgery Accreditation and Quality Improvement Program Accredited Center","volume":"26","author":"Clapp","year":"2022","journal-title":"JSLS"},{"issue":"10","key":"10.1016\/j.soard.2026.09.012_bib40","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1111\/dom.16619","article-title":"Adherence to GLP -1 receptor agonists and SGLT2 inhibitors by out-of-pocket spending among medicare beneficiaries with diabetes","volume":"27","author":"Klepser","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.soard.2026.09.012_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2025.0905","article-title":"Fiscal impact of expanded medicare coverage for GLP-1 receptor agonists to treat obesity","volume":"6","author":"Hwang","year":"2025","journal-title":"JAMA Health Forum"},{"issue":"8","key":"10.1016\/j.soard.2026.09.012_bib42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18553\/jmcp.2024.23332","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes","volume":"30","author":"Gleason","year":"2024","journal-title":"JMCP"},{"issue":"2","key":"10.1016\/j.soard.2026.09.012_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/SLA.0000000000006353","article-title":"Out-of-Pocket costs among commercially insured individuals with type 2 diabetes and obesity: Comparison between ozempic and sleeve gastrectomy","volume":"281","author":"Edwards","year":"2025","journal-title":"Ann Surg"}],"container-title":["Surgery for Obesity and Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728926009160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728926009160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:03:50Z","timestamp":1792267430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550728926009160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S1550728926009160"],"URL":"https:\/\/doi.org\/10.1016\/j.soard.2026.09.012","relation":{},"ISSN":["1550-7289"],"issn-type":[{"value":"1550-7289","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total healthcare costs and cost savings after bariatric surgery and glucagon-like peptide-1 receptor agonist treatment for obesity and diabetes vary with insurance coverage","name":"articletitle","label":"Article Title"},{"value":"Surgery for Obesity and Related Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soard.2026.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Metabolic and Bariatric Surgery.","name":"copyright","label":"Copyright"}]}}